The deal returns the drug-maker to the growing market for obesity drugs after scrapping an experimental weight-loss pill.

The cost of Mounjaro is about to increase, which has got many users considering switching to Wegova. Here we take a look at the differences between the two weight-loss drugs ...

The acquisition will mark Pfizer’s reentry into the weight-loss market after the failure of its GLP-1 drug candidate ...